Peptide APIs

Liraglutide

CAS No. 204656-20-2

A GLP-1 receptor agonist peptide used in injectable formulations for type 2 diabetes and chronic weight management.

Liraglutide is a fatty-acid-acylated GLP-1 analogue peptide API manufactured by NovaAcura Biotech under stringent GMP quality systems appropriate to peptide API handling. Full batch documentation and regulatory support are available for global formulation partners.

Applications & Uses

A GLP-1 receptor agonist peptide used in injectable formulations for type 2 diabetes and chronic weight management.

Full technical documentation, batch specifications and regulatory support (DMF/CEP) are available on request.

Need This Molecule at Scale?

Get in touch for pricing, lead times and full regulatory documentation.

Get In Touch